Patents
Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
05/2007
05/02/2007CN1313433C Novel dibenzocyclooctenes lignan and its preparation method and use
05/02/2007CN1313159C Hab18G/CD147 molecule small segment interfering RNA medicine and application thereof
05/02/2007CN1313156C Sodium alginate microglobule blood vessel suppositery containing gynecoiatry medicine and its preparation method
05/02/2007CN1313154C Medicine composition of adding active component which undissolved in water in carrier composition and its preparing method
05/02/2007CN1313146C Methods and compositions useful for inhibition of 'alpha'v'beta'5 mediated angiogenesis
05/02/2007CN1313145C Covalent conjugates between artemisinin-related endoperoxides and iron-carrying proteins and methods of use
05/02/2007CN1313136C Hemorrhoid-eliminating suppository and process for preparing the same
05/02/2007CN1313134C External-use traditional Chinese medicine for curing chronic rhinitis, nasosinusitis and laryngopharyngitis and its preparing method
05/02/2007CN1313117C Chinese medicine external applied powder for bone damage
05/02/2007CN1313115C Zoster treating ointment and its prepn
05/02/2007CN1313104C Anticancer medicine composition with synergistic bupleurum root and polymyxin
05/02/2007CN1313102C Health caring capsule of soft-shelled turtle and its preparation method
05/02/2007CN1313098C New use of achyranthes polysaccharide sulphate for anti Aids and immune regulation
05/02/2007CN1313097C Baby preparation containing free amino-acid and nucleotide
05/02/2007CN1313096C Asiaticoside use of medicinal preparation for treating and preventing chronic renal failure
05/02/2007CN1313095C Starter kit for low dose oral contraceptives
05/02/2007CN1313094C Use of ZD6474 in preparation of drug for treating cancer in human treated by ionising radiation
05/02/2007CN1313093C New application of berbamine as intracorporeal antitumor drug
05/02/2007CN1313092C Sustained-release tablet composition of pramipexole
05/02/2007CN1313091C Vitamin C composition
05/02/2007CN1313090C Aotomatic controlling nurve regulator and its health drinks and foods
05/02/2007CN1313089C Stimulation of CPT-1 as a means to reduce weight
05/02/2007CN1313088C Napthoquinone derivatives as inhibitors of tau aggregation for the treatment of alzheimer's and related neurodegenerative disorders
05/02/2007CN1313087C Preparation method for increasing dissolution of sofalcone
05/02/2007CN1313086C Aarin preparation for injection and preparing process thereof
05/02/2007CN1313085C Application of total hypone of radix cynanchi bungei and hypnone for preparing medicine for treating gastrointestinal tract diseases
05/02/2007CN1313084C Percutaneous contraceptive drugs delivery system and preparing method
05/02/2007CN1313083C Baofukang vagina film agent and its making method
05/02/2007CN1313082C Slow releasing composition and its preparing method
05/02/2007CN1313081C Valacycloguanosine tablet containing colloid silica
05/02/2007CN1313080C Improved water-insoluble drug particle preparing process
05/02/2007CN1313075C Composition containing semicrystalized polymer gelled liquid fatty phase
05/02/2007CN1313069C Composition for hair and/or scalp
05/02/2007CN1313030C Novel nutraceutical compositions comprising biotin
05/01/2007USRE39609 For decreasing intraocular pressure
05/01/2007USRE39608 Substituted benzimidazoles and their use as PARP inhibitors
05/01/2007USRE39606 Synthetic libraries of random oligomers, each member comprising an oligomer linked to a microchip encoded with information identifying structure of oligomer, for drug screening
05/01/2007US7211700 Such as 4-(tert-butyl)-2-(2-hydroxyphenyl)phenol; for use mouthwashes, antiperspirants
05/01/2007US7211696 Antileishmanial dinitroaniline sulfanomides with activity against parasite tubulin
05/01/2007US7211695 Trans-1,4-bis{N-[2-(4-hydroxy-3-hydroxymethylphenyl)-2-hydroxyethyl]amino}cyclohexane from aminating a dihydroxymethyl phenyl ketone with a diaminophenylene compound and a reducing agent; treating respiratory diseases, asthma, bronchitis, nervous system injury, premature labor
05/01/2007US7211694 Substituted 4-aminocyclohexanols
05/01/2007US7211680 (5Z,7E,22E)-(1S,3R,24R)-25-phenyl-26,27-cyclo-9,10-secocholesta-5,7,10(19),22-tetraene-1,3,24-triol; treating hyperprolifierative diseases of the skin, tumor diseases and precancerous stages, auto-immune diseases, rejection reactions in the case of autologous, allogenic or xenogenic transplants, AIDS
05/01/2007US7211677 3-amino-2-ethoxycarbonylpyrrole; chemical intermediate in synthesis of 3H,5H-pyrrolo[3,2-d]pyrimidin-4-one; a convergent synthesis route rather than a linear one
05/01/2007US7211672 PGD2 receptor antagonists for the treatment of inflammatory diseases
05/01/2007US7211670 Method for producing 3-amidinophenylalanine derivatives
05/01/2007US7211669 therapy for depression; anxiolytic agents; eating disorders; post-traumatic stress disorders; headaches; drug addition; antiinflammatory agents
05/01/2007US7211668 PNA monomer and precursor
05/01/2007US7211667 Trans,trans-1,3-butadiene-1,4-di-n-butyl-1-carboxyl-4-carboxamide; treating hypertension, associated with the decreased binding of magnesium to the plasma membranes of cells
05/01/2007US7211662 Soluble highly branched glucose polymers and their method of production
05/01/2007US7211656 Using the enzymes to make polyunsaturated fatty acids; added to pharmaceutical compositions, nutritional compositions, animal feeds, cosmetics
05/01/2007US7211653 1,4-Dideoxy-1-C-(4-hydroxypyrrolo[3,2-d]pyrimidin-7-yl)-1,4-imino-D-ribitol derivatives or salts; parasite purine nucleoside, -hydrolase, -phosphorylase and/or phosphoribosyl transferase inhibitors; antiprotozoa, anticarcinogenic, antiinflammatory, and immunosuppressant agents; autoimmune diseases
05/01/2007US7211648 Gag-peptide complex
05/01/2007US7211604 Hormone inhibitors comprising carbocyclic ketones such as 3-(5-methoxyheptyl)-2-cyclohexenone used for prophylaxis of acne, alopecia, keloids or osteoarthritis
05/01/2007US7211603 Enediyne compounds and methods related thereto
05/01/2007US7211602 Treatment of neurodegenerative disorders through the modulation of the polyamine pathway
05/01/2007US7211601 Prevention labor contraction; urogenital disorders
05/01/2007US7211600 Methods of modulating c-kit tyrosine protein kinase function with indolinone compounds
05/01/2007US7211599 Use of etodolac to treat hyperplasia
05/01/2007US7211598 Oxime and/or hydrozone containing nitrosated and/or nitrosylated cyclooxygenase-2 selective inhibitors, compositions and methods of use
05/01/2007US7211597 Antiinflammatory agents; rheumatic diseases; anticancer agents
05/01/2007US7211596 Stable high-concentration injection containing pyrazolone derivative
05/01/2007US7211595 Substituted imidazoles and thiazoles
05/01/2007US7211594 Indazole compounds and compositions thereof as JNK inhibitors and for the treatment of diseases associated therewith
05/01/2007US7211593 Anticancer agents; antiproliferative agents; viricides; autoimmune diseases
05/01/2007US7211592 Substituted an unsubstituted benzooxathiazoles and compounds derived therefrom
05/01/2007US7211591 Carboxylic acid derivative and a pharmaceutical composition containing the derivative as active ingredient
05/01/2007US7211590 Such as 2-(nitrooxy)ethyl-2-(((3-methyl-4-(2,2,2-trifluoro-ethoxy)-2 -pyridyl)methyl)sulfinyl)benzimidazolecarboxylate; kits; for treating gastrointestinal disorders/ulcers
05/01/2007US7211589 Atisane compounds and use thereof
05/01/2007US7211588 N-substituted indolyl-3-glyoxylamides, their use as medicaments and process for their preparation
05/01/2007US7211587 Administering compounds such as N-{3-Chloro-4-[(6,7-dimethoxy-4-quinolyl)-oxy]phenyl}-N'-(3-isoxazolyl)urea for therapy of malignant tumors
05/01/2007US7211586 Substituted tetrahydroisoquinolines
05/01/2007US7211585 N-[3-(3,4-Dihydro-1H-isoquinolin-2-yl)-propyl]-2-methyl-5-nitro-benzenesulfonamidehydrochloride; selective ligands of the 5-HT7 receptor; treating Central nervous system disorders
05/01/2007US7211584 N-[3-(3,4-Dihydro-1H-isoquinolin-2-yl)-propyl]-2-methyl-5-nitro-benzenesulfonamidehydrochloride; selective ligands of the 5-HT7 receptor; treating Central nervous system, pain, sleep disorder, shift worker syndrome, jet lag, depression, seasonal affective disorder, migraine, anxiety, psychosis
05/01/2007US7211583 Substituted azaindole as drugs and enzyme inhibitors
05/01/2007US7211582 Effective, non-sedating antihistamine for treating allergic rhinitis; avoiding adverse side-effects
05/01/2007US7211581 Substituted 2-(diaza-bicyclo-alkyl)-pyrimidone derivatives
05/01/2007US7211580 Compounds, compositions, and methods
05/01/2007US7211579 NK-1 receptor antagonists
05/01/2007US7211578 Nitrogenous tetrahydropyridyl-alkyl-heterocycles with TNF activity
05/01/2007US7211577 Water-soluble phenylpyridazine derivative and medicine containing the same
05/01/2007US7211576 Diaminothiazoles
05/01/2007US7211575 Methods of treating cytokine mediated diseases
05/01/2007US7211574 Central nervous system disorders; eating disorders; antidiabetic agents
05/01/2007US7211573 Malonamide derivatives
05/01/2007US7211572 Nitrogen-containing fused ring compound and use thereof as HIV integrase inhibitor
05/01/2007US7211571 Composition for the prevention and/or treatment of lipid metabolism disorders and allergic forms
05/01/2007US7211570 Administering 5-substituted uracil-nucleosides or its pharmaceutically acceptable salt or prodrug for therapy of infected with Epstein-Barr virus or Kaposi's sarcoma-associated herpes ("KHSV")
05/01/2007US7211568 9-Desoxoerythromycin compounds as prokinetic agents
05/01/2007US7211567 Administering kaempferol-3-glucoside orally in a food composition, in chewable tablet form or as a liquid, to a subject who suffers from pollinosis
05/01/2007US7211562 cytotoxic agents followed by a heat shock protein 90 inhibitor, has a synergistic effect on the growth inhibition of cells; destroying cells having a cell proliferative disorder with wild-type retinoblastoma gene
05/01/2007US7211561 Method for inducing selective cell death of malignant cells by activation of calcium-activated potassium channels (KCa)
05/01/2007US7211420 Oxidizing limonene or pinene or a cyclic sesquiterpene, wherein said limonene, pinene or cyclic sesquiterpene is optionally substituted by an alkyl of 1 to 6 carbons or an alkenyl of 1 to 6 carbons with a mutant haem-containing P450 enzyme, wherein mutant enzyme is a mutant of a P450BM-3
05/01/2007US7211417 from fermentation of Micromonospora; therapy for bacteria infections
05/01/2007US7211398 Human genes and gene expression products: II
05/01/2007US7211383 Calibrating polymorphism of human genome; therapy for skin disorders
05/01/2007US7211277 Cyclooxygenase-2 inhibitory withanolide compositions and method
05/01/2007US7211276 Method for preventing ulceration or irritation of mucosa
05/01/2007US7211274 Hair growth formulation
05/01/2007US7211267 Methods of treating acne
05/01/2007US7211257 Methods for inducing apoptosis in ovarian carcinoma cells using an anti-regeneration and tolerance factor antibody